Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02032758 · ClinicalTrials.gov registry record · Phase 4
Study of Arm and Putter Movement in Golfers With Golfer's Cramp
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
NCT02032758: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT02032758 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02032758, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
Study Summary
The investigators will investigate golfers with visual evidence of an involuntary movement while putting before and after treatment with a low dose of propranolol.
Interventions
- DRUG Propranolol
- DEVICE Opal Device
- PROCEDURE Science and Motion PuttLab (SAM)
- DEVICE Surface Electromyography EMG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02032758
The ClinicalTrials.gov registry entry for NCT02032758 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Propranolol is the first listed.
NCT02032758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02032758 about?
NCT02032758 is a clinical study titled "Study of Arm and Putter Movement in Golfers With Golfer's Cramp". The investigators will investigate golfers with visual evidence of an involuntary movement while putting before and after treatment with a low dose of propranolol.
What is the current status of trial NCT02032758?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2014-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02032758?
The interventions under investigation include: Propranolol (DRUG), Opal Device (DEVICE), Science and Motion PuttLab (SAM) (PROCEDURE), Surface Electromyography EMG (DEVICE).
Who is sponsoring clinical trial NCT02032758?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.